Mohammed S. Nofal
Mohammed S. Nofal
Pharmaceutical and Fermentation Industries Development Centre (PFIDC)
Verified email at
Cited by
Cited by
Nanoparticles of ZnO/Berberine complex contract COVID-19 and respiratory co-bacterial infection in addition to elimination of hydroxychloroquine toxicity
DA Ghareeb, SR Saleh, MG Seadawy, MS Nofal, SA Abdulmalek, ...
Journal of Pharmaceutical Investigation 51, 735-757, 2021
Berberine nanoencapsulation attenuates hallmarks of scoplomine induced Alzheimer's-like disease in rats
SR Saleh, MM Abady, M Nofal, NW Yassa, MS Abdel-Latif, MI Nounou, ...
Current Reviews in Clinical and Experimental Pharmacology Formerly Current …, 2021
Potential therapeutic and pharmacological strategies for SARS-CoV2
DA Ghareeb, SR Saleh, MS Nofal, MMY Kaddah, SF Hassan, IK Seif, ...
Journal of Pharmaceutical Investigation 51, 281-296, 2021
ZnO-chlorogenic acid nanostructured complex inhibits Covid-19 pathogenesis and increases hydroxychloroquine efficacy
MM Abomughaid, MS Nofal, KI Ghaleb, MG Seadawy, MG AbdEl-Wahab, ...
Journal of King Saud University-Science 34 (8), 102296, 2022
Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade
A Hamed, D Ghareeb, TM Mohamed, M Hamed, MS Nofal, M Gaber
BMC Complementary Medicine and Therapies 23 (1), 384, 2023
In vitro and in silico antioxidant and antidiabetic properties of zinc oxide-chlorogenic acid nanoparticles composite
A Albadawi, A Elkashef, M Nofel, M El-Salakawy, S Khalil, S Abdulmalek, ...
Alexandria Journal of Science and Technology, 1-15, 2024
The system can't perform the operation now. Try again later.
Articles 1–6